pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol VMP1   
Synonyms EPG3, TANGO5, TMEM49
Description vacuole membrane protein 1
Transcript NM_030938   
Expression
Putative miRNA Targets on VMP1
3'UTR of VMP1
(miRNA target sites are highlighted)
>VMP1|NM_030938|3'UTR
   1 GTAGAGAAAGTTTTAAACTGCAGAAATTGGAGTGGATGGGTTCTGCCTTAAATTGGGAGGACTCCAAGCCGGGAAGGAAA
  81 ATTCCCTTTTCCAACCTGTATCAATTTTTACAACTTTTTTCCTGAAAGCAGTTTAGTCCATACTTTGCACTGACATACTT
 161 TTTCCTTCTGTGCTAAGGTAAGGTATCCACCCTCGATGCAATCCACCTTGTGTTTTCTTAGGGTGGAATGTGATGTTCAG
 241 CAGCAAACTTGCAACAGACTGGCCTTCTGTTTGTTACTTTCAAAAGGCCCACATGATACAATTAGAGAATTCCCACCGCA
 321 CAAAAAAAGTTCCTAAGTATGTTAAATATGTCAAGCTTTTTAGGCTTGTCACAAATGATTGCTTTGTTTTCCTAAGTCAT
 401 CAAAATGTATATAAATTATCTAGATTGGATAACAGTCTTGCATGTTTATCATGTTACAATTTAATATTCCATCCTGCCCA
 481 ACCCTTCCTCTCCCATCCTCAAAAAAGGGCCATTTTATGATGCATTGCACACCCTCTGGGGAAATTGATCTTTAAATTTT
 561 GAGACAGTATAAGGAAAATCTGGTTGGTGTCTTACAAGTGAGCTGACACCATTTTTTATTCTGTGTATTTAGAATGAAGT
 641 CTTGAAAAAAACTTTATAAAGACATCTTTAATCATTCCAAAATTGTGTCCGTTTTCTTGAGCGTTTTGATTTTTTACTTT
 721 TAGCTTATACCAGCTGAATGGCAGCCTTGCCTAATCCACCTACAACAAGAATTTCTTAAGCTTTCTTTTATTTGCATGAG
 801 AGAGCCACTACCAAGGCATGTTTTGTTATGCTGAAACTGGGCTGCTGCATACTGCTAAATGGCACCTCTGGGATTGGCCT
 881 ACCTGGGGATTTCTTGGTTTGTGAAAACAGGAGAGGAGAAATATCTCATACAAGTGAAAGGATACTGGAGAGAGAAATTA
 961 CCCATTTCTAAAAAAAAACCACACTCTGTCGTATCTGTGTTAATGTTTTCTAGCATGTACTCTGGTTTCAACAGACACAA
1041 ATTTATATGTTAACCCAGTTTTCTTGCCGTTCTGTAAGTGTTTTATTCTTAGTGTGATTTTTTTCCATTGGGATGTTTTT
1121 GATTGAACTTGTTCATTTTGTTTTGCTTGGGAGGAAAATAAACAATTTTACTTTTTTCCTTTAGGAGCATTATGAGCATT
1201 ATGTCAGAATAGAATAGAATTGGGGTTCGATCTTAACAGGCCAGAAATGCCTGGGTTTTTTTGGTTTGTTTTTGTTTTTG
1281 TTTTTTTATCAAATCCTGCCTGACTGTCTGCTTGTTTTGCCTACCATCGTGACATCTCCATGGCTGTACCACCTTGTCGG
1361 GTAGCTTATCAGACTGATGTTGACTGTTGAATCTCATGGCAACACCAGTCGATGGGCTGTCTGACATTTTGGTATCTTTC
1441 ATCTGACCATCCATATCCAATGTTCTCATTTAAACATTACCCAGCATCATTGTTTATAATCAGAAACTCTGGTCCTTCTG
1521 TCTGGTGGCACTTAGAGTCTTTTGTGCCATAATGCAGCAGTATGGAGGGAGGATTTTATGGAGAAATGGGGATAGTCTTC
1601 ATGACCACAAATAAATAAAGGAAAACTAAGCTGCATTGTGGGTTTTGAAAAGGTTATTATACTTCTTAACAATTCTTTTT
1681 TTCAGGGACTTTTCTAGCTGTATGACTGTTACTTGACCTTCTTTGAAAAGCATTCCCAAAATGCTCTATTTTAGATAGAT
1761 TAACATTAACCAACATAATTTTTTTTAGATCGAGTCAGCATAAATTTCTAAGTCAGCCTCTAGTCGTGGTTCATCTCTTT
1841 CACCTGCATTTTATTTGGTGTTTGTCTGAAGAAAGGAAAGAGGAAAGCAAATACGAATTGTACTATTTGTACCAAATCTT
1921 TGGGATTCATTGGCAAATAATTTCAGTGTGGTGTATTATTAAATAGAAAAAAAAAATTTTGTTTCCTAGGTTGAAGGTCT
2001 AATTGATACGTTTGACTTATGATGACCATTTATGCACTTTCAAATGAATTTGCTTTCAAAATAAATGAAGAGCAGCTGTC
2081 CTTCTTTCCTCTTTTAAGTGTTCAGCTGTGGCATGCTCAGAGGTTCCTGCTGGATTCCAGCTGGAGCGGTGTGATACCCT
2161 TCTTTTTCAGCTGTTCGTGCCTTCCTTTCTTGTATCCACCAAAGTGGAGACAAATACATGATCTCAAAGATACACAGTAC
2241 CTACTTAATTCCAGCTGATGGGAGACCAAAGAATTTGCAAGTGGATGGTTTGGTATCACTGTAAATAAAAAGAGGGCCTG
2321 GGAATTCTTGCGATTCCATCTCTAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agucGGCGACAGUGUGCGUGUc 5'
              | ||||| :||:|| || 
Target 5' tgttCAGCTGTGGCATGCTCAg 3'
2099 - 2120 122.00 -21.20
2
miRNA  3' agucggcgacaguguGCGUGUc 5'
                         |||||| 
Target 5' ttagagaattcccacCGCACAa 3'
302 - 323 120.00 -11.50
3
miRNA  3' agucgGCGAC-AGU--GUGCGUGuc 5'
               :| ||  ||  :|:||||  
Target 5' acttaTGATGACCATTTATGCACtt 3'
2015 - 2039 107.00 -8.10
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN3088458 2 COSMIC
COSN8866375 5 COSMIC
COSN13735757 14 COSMIC
COSN30536658 19 COSMIC
COSN511190 43 COSMIC
COSN30147540 58 COSMIC
COSN30510454 67 COSMIC
COSN31569432 70 COSMIC
COSN30465155 74 COSMIC
COSN30148576 78 COSMIC
COSN30461441 87 COSMIC
COSN16877327 99 COSMIC
COSN30187042 110 COSMIC
COSN30536317 144 COSMIC
COSN30161109 150 COSMIC
COSN30103831 151 COSMIC
COSN24393434 165 COSMIC
COSN31536607 186 COSMIC
COSN31485273 195 COSMIC
COSN8603509 197 COSMIC
COSN30120953 268 COSMIC
COSN22853757 274 COSMIC
COSN22832017 297 COSMIC
COSN24369933 299 COSMIC
COSN31551001 434 COSMIC
COSN31488759 493 COSMIC
COSN8244669 511 COSMIC
COSN31489322 562 COSMIC
COSN20731338 596 COSMIC
COSN31481279 646 COSMIC
COSN32012210 685 COSMIC
COSN31482736 700 COSMIC
COSN31515779 713 COSMIC
COSN23066883 734 COSMIC
COSN25647925 734 COSMIC
COSN28640523 737 COSMIC
COSN16445293 895 COSMIC
COSN14503248 956 COSMIC
COSN27417343 960 COSMIC
COSN22895834 979 COSMIC
COSN23704751 987 COSMIC
COSN25448323 1050 COSMIC
COSN30140581 1127 COSMIC
COSN30109282 1152 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1437920068 3 dbSNP
rs770031145 4 dbSNP
rs1281935777 5 dbSNP
rs1447860002 7 dbSNP
rs777974368 8 dbSNP
rs200069029 10 dbSNP
rs1357657602 11 dbSNP
rs759655381 11 dbSNP
rs1348949165 12 dbSNP
rs767544899 12 dbSNP
rs771600003 14 dbSNP
rs774858546 16 dbSNP
rs201304021 19 dbSNP
rs1453402102 22 dbSNP
rs144971888 27 dbSNP
rs369547349 33 dbSNP
rs1268249235 34 dbSNP
rs752847407 44 dbSNP
rs776215056 47 dbSNP
rs1285389109 56 dbSNP
rs917028815 63 dbSNP
rs1184831949 64 dbSNP
rs112911537 71 dbSNP
rs531167928 72 dbSNP
rs186654540 77 dbSNP
rs1046748823 78 dbSNP
rs1255769741 79 dbSNP
rs1204830627 81 dbSNP
rs1050198073 91 dbSNP
rs889238273 97 dbSNP
rs1270304312 98 dbSNP
rs567469307 99 dbSNP
rs1008974740 101 dbSNP
rs112275511 102 dbSNP
rs967405699 114 dbSNP
rs1317004305 116 dbSNP
rs999237159 117 dbSNP
rs191589648 119 dbSNP
rs1033276903 136 dbSNP
rs957598965 139 dbSNP
rs1005433784 141 dbSNP
rs991681913 148 dbSNP
rs1443264544 151 dbSNP
rs916080723 153 dbSNP
rs1356443615 155 dbSNP
rs1166825358 158 dbSNP
rs1429108882 159 dbSNP
rs1386420295 186 dbSNP
rs1166096406 187 dbSNP
rs998055343 193 dbSNP
rs541115112 195 dbSNP
rs546649647 202 dbSNP
rs1029899299 206 dbSNP
rs1481430222 206 dbSNP
rs1203829774 207 dbSNP
rs1206177895 221 dbSNP
rs954853783 227 dbSNP
rs142077942 239 dbSNP
rs1321025528 251 dbSNP
rs1212994520 253 dbSNP
rs1375802494 260 dbSNP
rs1270469593 263 dbSNP
rs1480550514 265 dbSNP
rs1229959140 269 dbSNP
rs1306343789 270 dbSNP
rs79798956 294 dbSNP
rs940387575 300 dbSNP
rs767245736 302 dbSNP
rs1366320193 306 dbSNP
rs1305013410 314 dbSNP
rs753071850 318 dbSNP
rs557241636 319 dbSNP
rs1410195623 322 dbSNP
rs575435829 325 dbSNP
rs1050254776 327 dbSNP
rs1490402605 330 dbSNP
rs1407211157 336 dbSNP
rs182811044 350 dbSNP
rs1305011711 355 dbSNP
rs1261167789 357 dbSNP
rs1217688562 373 dbSNP
rs1009106404 375 dbSNP
rs1314966283 379 dbSNP
rs1287459383 383 dbSNP
rs1228072497 384 dbSNP
rs1040478303 386 dbSNP
rs903234975 387 dbSNP
rs998893089 395 dbSNP
rs1032996485 396 dbSNP
rs1390664961 409 dbSNP
rs1301538867 419 dbSNP
rs957649960 421 dbSNP
rs1158861556 430 dbSNP
rs1480571111 434 dbSNP
rs1046766751 437 dbSNP
rs1196134628 440 dbSNP
rs1013168709 441 dbSNP
rs1240246421 443 dbSNP
rs1261795007 451 dbSNP
rs1279376820 452 dbSNP
rs1463473847 453 dbSNP
rs1023190724 456 dbSNP
rs1204020533 460 dbSNP
rs1324545271 470 dbSNP
rs568339996 474 dbSNP
rs1349130900 479 dbSNP
rs941007289 489 dbSNP
rs1039326321 496 dbSNP
rs1330667776 501 dbSNP
rs573031484 503 dbSNP
rs540330040 509 dbSNP
rs1384470141 520 dbSNP
rs998504596 531 dbSNP
rs1320341252 534 dbSNP
rs1050985078 535 dbSNP
rs927750100 537 dbSNP
rs1490370600 547 dbSNP
rs1407859942 549 dbSNP
rs1221208795 557 dbSNP
rs1465226811 563 dbSNP
rs1373201041 566 dbSNP
rs1194640663 573 dbSNP
rs564797253 574 dbSNP
rs962087615 575 dbSNP
rs576787208 576 dbSNP
rs1247272630 583 dbSNP
rs892256474 584 dbSNP
rs1253813500 591 dbSNP
rs1198989399 609 dbSNP
rs971796164 610 dbSNP
rs1264859378 635 dbSNP
rs543847143 642 dbSNP
rs1229650218 648 dbSNP
rs1439301302 652 dbSNP
rs968722919 654 dbSNP
rs1182224843 655 dbSNP
rs1000220885 656 dbSNP
rs920253116 674 dbSNP
rs879381390 682 dbSNP
rs959020230 692 dbSNP
rs993483903 694 dbSNP
rs1424122163 702 dbSNP
rs1427203215 703 dbSNP
rs1050306254 704 dbSNP
rs1398867882 711 dbSNP
rs1164208658 723 dbSNP
rs141096699 725 dbSNP
rs1392232432 730 dbSNP
rs951521366 738 dbSNP
rs982515202 746 dbSNP
rs1186518500 754 dbSNP
rs909658652 758 dbSNP
rs1251428789 772 dbSNP
rs941103734 782 dbSNP
rs910444975 783 dbSNP
rs1454982883 786 dbSNP
rs944566722 797 dbSNP
rs147014610 799 dbSNP
rs186805777 803 dbSNP
rs1359479375 806 dbSNP
rs1359024682 807 dbSNP
rs879476782 807 dbSNP
rs561155694 813 dbSNP
rs1040596117 817 dbSNP
rs1244438929 818 dbSNP
rs754374590 829 dbSNP
rs1330543548 838 dbSNP
rs934741606 843 dbSNP
rs1407611456 862 dbSNP
rs1369444144 870 dbSNP
rs1303206183 872 dbSNP
rs1426498853 873 dbSNP
rs933927723 874 dbSNP
rs1162435980 880 dbSNP
rs1054496151 897 dbSNP
rs1244647899 898 dbSNP
rs1470356083 909 dbSNP
rs1263213908 911 dbSNP
rs1341014262 914 dbSNP
rs893152141 931 dbSNP
rs1471713395 934 dbSNP
rs1251232968 941 dbSNP
rs1051417540 945 dbSNP
rs548373048 946 dbSNP
rs138171828 949 dbSNP
rs1456281251 963 dbSNP
rs1043558276 970 dbSNP
rs904636232 970 dbSNP
rs547096758 971 dbSNP
rs112373467 979 dbSNP
rs1226243789 979 dbSNP
rs112394324 980 dbSNP
rs1003071912 981 dbSNP
rs1181804616 984 dbSNP
rs1437905953 984 dbSNP
rs1322875045 986 dbSNP
rs1401210135 987 dbSNP
rs1374916851 988 dbSNP
rs1386914903 989 dbSNP
rs1016174144 991 dbSNP
rs961855087 992 dbSNP
rs1200252252 1008 dbSNP
rs142172135 1018 dbSNP
rs1245052086 1021 dbSNP
rs1198827967 1025 dbSNP
rs745928712 1033 dbSNP
rs951731123 1055 dbSNP
rs1207171564 1062 dbSNP
rs1328050649 1067 dbSNP
rs1382658386 1069 dbSNP
rs183455127 1070 dbSNP
rs951614162 1074 dbSNP
rs982941949 1079 dbSNP
rs1364955496 1086 dbSNP
rs1309940235 1096 dbSNP
rs1327753009 1098 dbSNP
rs3851812 1099 dbSNP
rs150139981 1106 dbSNP
rs975531134 1108 dbSNP
rs1205295782 1110 dbSNP
rs910495786 1112 dbSNP
rs1434017649 1114 dbSNP
rs1406530208 1116 dbSNP
rs1263581622 1131 dbSNP
rs944601328 1136 dbSNP
rs536557799 1155 dbSNP
rs1460805778 1160 dbSNP
rs975983148 1173 dbSNP
rs1423214626 1176 dbSNP
rs1198723936 1180 dbSNP
rs1263857759 1184 dbSNP
rs34573816 1184 dbSNP
rs138847109 1197 dbSNP
rs1250372494 1201 dbSNP
rs1187083055 1210 dbSNP
rs1464774163 1211 dbSNP
rs566692719 1215 dbSNP
rs933622145 1218 dbSNP
rs1192677882 1222 dbSNP
rs188041455 1226 dbSNP
rs558653671 1229 dbSNP
rs1310049508 1230 dbSNP
rs1277323511 1231 dbSNP
rs986751768 1232 dbSNP
rs1481567281 1235 dbSNP
rs149373146 1238 dbSNP
rs544241065 1254 dbSNP
rs570199250 1256 dbSNP
rs555877935 1257 dbSNP
rs934478769 1261 dbSNP
rs111890520 1262 dbSNP
rs1383310068 1265 dbSNP
rs1304347751 1267 dbSNP
rs1054548887 1272 dbSNP
rs1468697114 1275 dbSNP
rs747140673 1278 dbSNP
rs1357604554 1280 dbSNP
rs1043613187 1281 dbSNP
rs893202899 1290 dbSNP
rs1386417978 1300 dbSNP
rs1392086942 1302 dbSNP
rs1382320848 1304 dbSNP
rs1167334826 1305 dbSNP
rs761498169 1309 dbSNP
rs79800958 1311 dbSNP
rs749958953 1312 dbSNP
rs772840282 1314 dbSNP
rs1003528503 1329 dbSNP
rs193062491 1330 dbSNP
rs368618785 1332 dbSNP
rs561219368 1333 dbSNP
rs781007656 1337 dbSNP
rs752908264 1340 dbSNP
rs1456453169 1341 dbSNP
rs756424073 1345 dbSNP
rs1238694848 1350 dbSNP
rs372920017 1353 dbSNP
rs749388493 1359 dbSNP
rs1220507102 1360 dbSNP
rs375409923 1362 dbSNP
rs779350466 1373 dbSNP
rs1182837899 1378 dbSNP
rs1253814784 1380 dbSNP
rs746383582 1387 dbSNP
rs772365223 1406 dbSNP
rs540457553 1407 dbSNP
rs1332902069 1408 dbSNP
rs1360004766 1409 dbSNP
rs1314650731 1411 dbSNP
rs747325963 1412 dbSNP
rs1161253978 1415 dbSNP
rs1377260723 1427 dbSNP
rs755966556 1427 dbSNP
rs1364448024 1435 dbSNP
rs769439553 1437 dbSNP
rs1014694729 1442 dbSNP
rs1372527933 1445 dbSNP
rs772793198 1447 dbSNP
rs1391304001 1448 dbSNP
rs199635526 1451 dbSNP
rs1234632017 1455 dbSNP
rs887396706 1456 dbSNP
rs765868317 1459 dbSNP
rs1004420391 1461 dbSNP
rs1017061773 1462 dbSNP
rs371946109 1463 dbSNP
rs951783463 1466 dbSNP
rs985781023 1470 dbSNP
rs1342981296 1475 dbSNP
rs759493482 1477 dbSNP
rs1177470522 1480 dbSNP
rs1473356540 1483 dbSNP
rs1428950304 1515 dbSNP
rs1017688392 1518 dbSNP
rs1203764502 1520 dbSNP
rs996620345 1520 dbSNP
rs532499147 1522 dbSNP
rs955131029 1524 dbSNP
rs571607618 1526 dbSNP
rs1219262643 1528 dbSNP
rs976414345 1531 dbSNP
rs1229291575 1534 dbSNP
rs1307401884 1534 dbSNP
rs1352502230 1535 dbSNP
rs1286563383 1540 dbSNP
rs1409212488 1544 dbSNP
rs1368383561 1554 dbSNP
rs1295873443 1570 dbSNP
rs1456816576 1572 dbSNP
rs913562384 1578 dbSNP
rs924515332 1579 dbSNP
rs934499775 1589 dbSNP
rs1453737041 1591 dbSNP
rs1180845466 1607 dbSNP
rs1433323920 1609 dbSNP
rs989954427 1610 dbSNP
rs1297024543 1613 dbSNP
rs914688617 1618 dbSNP
rs966656345 1627 dbSNP
rs1439201598 1633 dbSNP
rs979303393 1636 dbSNP
rs1292037 1637 dbSNP
rs530084900 1641 dbSNP
rs548516610 1647 dbSNP
rs928634300 1649 dbSNP
rs1228014783 1650 dbSNP
rs938655984 1651 dbSNP
rs767337696 1663 dbSNP
rs916009866 1667 dbSNP
rs1303478483 1670 dbSNP
rs138230604 1694 dbSNP
rs1385615174 1701 dbSNP
rs1367469481 1703 dbSNP
rs1037707400 1707 dbSNP
rs534020051 1714 dbSNP
rs1386891552 1718 dbSNP
rs1158047038 1734 dbSNP
rs1466202924 1737 dbSNP
rs558467512 1738 dbSNP
rs995659076 1740 dbSNP
rs1190285819 1744 dbSNP
rs1463431683 1748 dbSNP
rs13137 1760 dbSNP
rs1204829841 1768 dbSNP
rs887565606 1776 dbSNP
rs1257866996 1777 dbSNP
rs1231076877 1778 dbSNP
rs1312138429 1779 dbSNP
rs1299070757 1782 dbSNP
rs1007257623 1787 dbSNP
rs1231249665 1792 dbSNP
rs1238317756 1793 dbSNP
rs77524042 1795 dbSNP
rs1396268898 1806 dbSNP
rs760179074 1808 dbSNP
rs887071666 1809 dbSNP
rs759883745 1820 dbSNP
rs117526670 1826 dbSNP
rs574116856 1827 dbSNP
rs1032020731 1834 dbSNP
rs1268473900 1849 dbSNP
rs541392445 1859 dbSNP
rs537258457 1863 dbSNP
rs955929117 1868 dbSNP
rs997444904 1871 dbSNP
rs1028475970 1876 dbSNP
rs1389350194 1888 dbSNP
rs9892710 1896 dbSNP
rs1443220933 1905 dbSNP
rs1258461651 1906 dbSNP
rs372195937 1906 dbSNP
rs1198935363 1908 dbSNP
rs35378558 1909 dbSNP
rs914405935 1909 dbSNP
rs1418999910 1910 dbSNP
rs969844252 1914 dbSNP
rs1157386675 1919 dbSNP
rs753322532 1925 dbSNP
rs554880804 1930 dbSNP
rs573180098 1937 dbSNP
rs1297359629 1967 dbSNP
rs928711613 1967 dbSNP
rs966333177 1967 dbSNP
rs979362455 1976 dbSNP
rs1395062408 1977 dbSNP
rs925216010 1977 dbSNP
rs938693725 1978 dbSNP
rs1309269820 1979 dbSNP
rs536368995 1982 dbSNP
rs918861007 1987 dbSNP
rs1369803273 1998 dbSNP
rs1299660582 2001 dbSNP
rs754107076 2002 dbSNP
rs140179094 2010 dbSNP
rs1390683088 2011 dbSNP
rs889962710 2013 dbSNP
rs1252653775 2019 dbSNP
rs1207327344 2020 dbSNP
rs532690447 2021 dbSNP
rs1039215349 2023 dbSNP
rs142424076 2028 dbSNP
rs997621557 2033 dbSNP
rs1045760364 2034 dbSNP
rs1358957291 2070 dbSNP
rs1264029363 2076 dbSNP
rs1232328186 2081 dbSNP
rs185482676 2082 dbSNP
rs1407391095 2092 dbSNP
rs908564572 2092 dbSNP
rs939999140 2099 dbSNP
rs1324203670 2101 dbSNP
rs1038314655 2104 dbSNP
rs1388367553 2105 dbSNP
rs1162381502 2119 dbSNP
rs1044323 2121 dbSNP
rs530151108 2124 dbSNP
rs548580878 2125 dbSNP
rs1011507286 2143 dbSNP
rs1206971027 2144 dbSNP
rs1412886089 2148 dbSNP
rs1021512669 2149 dbSNP
rs1232366637 2159 dbSNP
rs969896465 2167 dbSNP
rs1252181327 2173 dbSNP
rs1480516925 2177 dbSNP
rs979930819 2178 dbSNP
rs1329452572 2182 dbSNP
rs1269695579 2183 dbSNP
rs1044327 2184 dbSNP
rs139533127 2195 dbSNP
rs1020686266 2197 dbSNP
rs1438546909 2198 dbSNP
rs1044329 2199 dbSNP
rs973181913 2216 dbSNP
rs1183647256 2223 dbSNP
rs1044331 2235 dbSNP
rs552408039 2236 dbSNP
rs1403244572 2255 dbSNP
rs931282085 2258 dbSNP
rs189940979 2264 dbSNP
rs1464928690 2270 dbSNP
rs1455824604 2272 dbSNP
rs538017437 2278 dbSNP
rs1032003856 2291 dbSNP
rs1173194429 2293 dbSNP
rs1479292697 2295 dbSNP
rs879128047 2298 dbSNP
rs878931702 2299 dbSNP
rs911452535 2318 dbSNP
rs942877926 2321 dbSNP
rs549481356 2325 dbSNP
rs959591033 2332 dbSNP
rs901613970 2333 dbSNP
rs970559216 2338 dbSNP
rs981511431 2340 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293T , SMMC-7721 , Huh-7
Location of target site 3'UTR
Tools used in this research TargetScan
Original Description (Extracted from the article) ... VMP1 Is the Direct Downstream Target of miR- 210 in HCC ...

- Ying Q; Liang L; Guo W; Zha R; Tian Q; et al., 2011, Hepatology (Baltimore, Md.).

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' agucggcgacaguguGCGUGUc 5'
                         |||||| 
Target 5' uuagagaauucccacCGCACAa 3'
1 - 22
Article - Ying Q; Liang L; Guo W; Zha R; Tian Q; et al.
- Hepatology (Baltimore, Md.), 2011
UNLABELLED: As the "master" microRNA that is induced by hypoxia, miR-210 is involved in multiple processes in the hypoxia pathway. However, whether miR-210 mediates hypoxia-induced tumor cell metastasis still remains unclear. Here, we demonstrate that miR-210 is frequently up-regulated in hepatocellular carcinoma (HCC) samples and promotes the migration and invasion of HCC cells. Furthermore, miR-210 can be induced by hypoxia in HCC cells and mediates hypoxia-induced HCC cell metastasis. We identify vacuole membrane protein 1 (VMP1) as the direct and functional downstream target of miR-210; in addition, we show that its expression is negatively correlated with the expression of miR-210 in HCC. Intriguingly, VMP1 is reduced by hypoxia, and down-regulation of VMP1 by miR-210 mediates hypoxia-induced HCC cell metastasis. CONCLUSION: These findings extend our understanding of the function of miR-210 in the hypoxia pathway, and this newly identified hypoxia/miR-210/VMP1 pathway should facilitate the development of novel therapeutics against hypoxic tumor cells.
LinkOut: [PMID: 22144109]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HCT-116 , HT-29 , SW620 , SW480
Disease Colorectal cancer
Location of target site 3'UTR
Tools used in this research TargetScan
Article - Qu A; Du L; Yang Y; Liu H; Li J; Wang L; et al.
- PloS one, 2014
MicroRNA-210 (miR-210), the master hypoxamir, plays pleiotropic roles in certain cancers; however, its role in the development of human colorectal cancer remains unclear. Herein, we report that miR-210 is frequently up-regulated in colorectal cancer tissues, with high miR-210 expression significantly correlating with large tumor size, lymph node metastasis, advanced clinical stage and poor prognosis. Functionally, miR-210 overexpression promotes the migration and invasion of colorectal cancer cells. Furthermore, miR-210 can be induced by hypoxia and mediates the hypoxia-induced metastasis of colorectal cancer cells. In addition, vacuole membrane protein 1 (VMP1) is identified as the direct and functional target of miR-210. Thus, miR-210 is a useful biomarker for hypoxic tumor cells and a prognostic factor that plays an essential role in colorectal cancer metastasis.
LinkOut: [PMID: 24632577]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
THCA 0.327 0.01 0.276 0.02 59 Click to see details
KIRC 0.256 0.02 0.240 0.02 68 Click to see details
STAD 0.308 0.04 0.274 0.06 32 Click to see details
BLCA 0.373 0.06 0.472 0.02 18 Click to see details
PRAD -0.212 0.07 -0.235 0.05 50 Click to see details
LUSC -0.244 0.07 -0.140 0.2 38 Click to see details
LIHC 0.213 0.07 0.228 0.06 49 Click to see details
KICH 0.266 0.1 0.233 0.13 25 Click to see details
KIRP 0.217 0.12 0.179 0.16 32 Click to see details
CHOL -0.417 0.13 -0.433 0.12 9 Click to see details
COAD -0.443 0.14 -0.357 0.19 8 Click to see details
PAAD 0.627 0.19 0.400 0.3 4 Click to see details
ESCA 0.29 0.19 0.309 0.18 11 Click to see details
UCEC -0.176 0.24 -0.156 0.26 19 Click to see details
CESC -0.687 0.26 -0.500 0.33 3 Click to see details
HNSC 0.102 0.26 0.099 0.27 42 Click to see details
LUAD 0.128 0.35 0.161 0.31 12 Click to see details
BRCA -0.023 0.42 -0.034 0.38 84 Click to see details
PCPG 0.248 0.42 -0.500 0.33 3 Click to see details
PCPG 0.248 0.42 -0.500 0.33 3 Click to see details
PCPG 0.248 0.42 -0.500 0.33 3 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission